{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:21:33Z","timestamp":1779186093685,"version":"3.51.4"},"reference-count":48,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin, Poland","award":["DS 23\/2023"],"award-info":[{"award-number":["DS 23\/2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders.<\/jats:p>","DOI":"10.3390\/molecules28083575","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T02:01:11Z","timestamp":1681956071000},"page":"3575","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of Seltorexant\u2014Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-3926","authenticated-orcid":false,"given":"Wojciech","family":"Ziemich\u00f3d","sequence":"first","affiliation":[{"name":"Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-8767","authenticated-orcid":false,"given":"Antonina","family":"Kurowska","sequence":"additional","affiliation":[{"name":"Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-4435","authenticated-orcid":false,"given":"Karolina","family":"Grabowska","sequence":"additional","affiliation":[{"name":"Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6997-5760","authenticated-orcid":false,"given":"Michalina","family":"Kurowska","sequence":"additional","affiliation":[{"name":"Institute of Applied Psychology, Jagiellonian University, 31-007 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Bia\u0142a","sequence":"additional","affiliation":[{"name":"Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Steiner, M.A., Yanagisawa, M., and Clozel, M. (2021). The Orexin System. Basic Science and Role in Sleep Pathology, Karger Medical and Scientific Publishers.","DOI":"10.1159\/isbn.978-3-318-06844-3"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/hbeh.2000.1584","article-title":"Differential Distribution and Regulation of OX1 and OX2 Orexin\/Hypocretin Receptor Messenger RNA in the Brain upon Fasting","volume":"37","author":"Lu","year":"2000","journal-title":"Horm. Behav."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2017.00357","article-title":"Orexin System: The Key for a Healthy Life","volume":"8","author":"Chieffi","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/0974-8369.1000248","article-title":"Role of Orexin System in Obesity","volume":"7","author":"Messina","year":"2015","journal-title":"Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.2010.05513.x","article-title":"The orexin system: Roles in sleep\/wake regulation","volume":"1200","author":"Sakurai","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","article-title":"Promotion of Sleep by Suvorexant\u2014A Novel Dual Orexin Receptor Antagonist","volume":"25","author":"Winrow","year":"2011","journal-title":"J. Neurogenet."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ziemich\u00f3d, W., Grabowska, K., Kurowska, A., and Bia\u0142a, G. (2022). A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia. Molecules, 27.","DOI":"10.3390\/molecules27186041"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","article-title":"Lemborexant: First Approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tips.2006.05.006","article-title":"The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions","volume":"27","author":"Zeitzer","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-894X(02)00851-X","article-title":"Development of an orexin-2 receptor selective agonist, [Ala11, d-Leu15]orexin-B","volume":"13","author":"Asahi","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12264-019-00447-9","article-title":"Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders","volume":"36","author":"Han","year":"2019","journal-title":"Neurosci. Bull."},{"key":"ref_13","unstructured":"Murray, C.J., and Lopez, A.D. (1996). The Global Burden of Disease, Harvard University Press."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Moncrieff, J., Cooper, R.E., Stockmann, T., Amendola, S., Hengartner, M.P., and Horowitz, M.A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Mol. Psychiatry, 1\u201314.","DOI":"10.1038\/s41380-022-01661-0"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000318293","article-title":"Efficacy and Effectiveness of Antidepressants: Current Status of Research","volume":"79","author":"Pigott","year":"2010","journal-title":"Psychother. Psychosom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the orexin\/hypocretin system in stress-related psychiatric disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top Behav. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.1038\/ncomms12199","article-title":"Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons","volume":"7","author":"Tung","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson","year":"2009","journal-title":"Nat. Med."},{"key":"ref_20","first-page":"244","article-title":"Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats","volume":"23","author":"James","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.mp.4001345","article-title":"Selectively bred Wistar\u2014Kyoto rats: An animal model of depression and hyper-responsiveness to antidepressants","volume":"8","author":"Will","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001756-200103050-00008","article-title":"Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats","volume":"12","author":"Taheri","year":"2001","journal-title":"Neuroreport"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.npep.2004.06.004","article-title":"Stereological analysis of the hypothalamic hypocretin\/orexin neurons in an animal model of depression","volume":"38","author":"Allard","year":"2004","journal-title":"Neuropeptides"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2014.04.069","article-title":"Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency","volume":"272","author":"Deats","year":"2014","journal-title":"Neuroscience"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.regpep.2014.11.003","article-title":"Orexin administration to mice that underwent chronic stress produces bimodal effects on emotion-related behaviors","volume":"194\u2013195","author":"Chung","year":"2014","journal-title":"Regul. Pept."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2011.07.010","article-title":"Increased numbers of orexin\/hypocretin neurons in a genetic rat depression model","volume":"45","author":"Mikrouli","year":"2011","journal-title":"Neuropeptides"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/13651501.2018.1551549","article-title":"Orexin\/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder","volume":"23","author":"Cengiz","year":"2018","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2006.10.019","article-title":"Orexin and psychiatric symptoms in suicide attempters","volume":"100","author":"Brundin","year":"2007","journal-title":"J. Affect. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2008.04.011","article-title":"Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt","volume":"113","author":"Brundin","year":"2009","journal-title":"J. Affect. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0028-3908(00)00178-7","article-title":"Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat","volume":"40","author":"Brown","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The Orexin\/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1523\/JNEUROSCI.22-21-09453.2002","article-title":"Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions","volume":"22","author":"Liu","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/npp.2012.38","article-title":"Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia","volume":"37","author":"Johnson","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_34","first-page":"201","article-title":"SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats","volume":"31","author":"Jaz","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2018.04.005","article-title":"Sex- and Age-dependent Effects of Orexin 1 Receptor Blockade on Open-Field Behavior and Neuronal Activity","volume":"381","author":"Blume","year":"2018","journal-title":"Neuroscience"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/WNR.0000000000000660","article-title":"The role of trigeminal nucleus caudalis orexin 1 receptor in orofacial pain-induced anxiety in rat","volume":"27","author":"Bahaaddini","year":"2016","journal-title":"Neuroreport"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/da.22403","article-title":"Orexin 1 and 2 receptor involvement in CO-induced panic\u2013associated behavior and autonomic responses","volume":"32","author":"Johnson","year":"2015","journal-title":"Depression Anxiety"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1021\/acs.jmedchem.5b00742","article-title":"Novel octahydropyrrolo [3,4-c]pyrroles are selective orexin-2 antagonists: SAR leading to a clinical candidate","volume":"58","author":"Letavic","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/jpet.115.225466","article-title":"Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia","volume":"354","author":"Bonaventure","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ejoc.201901519","article-title":"Synthesis of 2-Substituted 1, 2, 3-Triazoles via an Intramolecular N\u2013N Bond Formation","volume":"2020","author":"Chen","year":"2020","journal-title":"Eur. J. Org. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105779","DOI":"10.1016\/j.bioorg.2022.105779","article-title":"Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging","volume":"123","author":"Bai","year":"2022","journal-title":"Bioorg. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnbeh.2017.00083","article-title":"Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in Mice","volume":"11","author":"Yun","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0269881118773745","article-title":"A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity","volume":"32","author":"Drevets","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/0269881118791521","article-title":"Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects","volume":"32","author":"Golor","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41398-019-0553-z","article-title":"The selective orexin-2 antagonist seltorexant (JNJ-42847922\/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder","volume":"9","author":"Recourt","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ijnp\/pyab050","article-title":"Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study","volume":"24","author":"Savitz","year":"2021","journal-title":"Int. Neuropsychopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: A systematic review and network meta-analysis","volume":"400","author":"Ostinelli","year":"2022","journal-title":"Lancet"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/8\/3575\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:19:01Z","timestamp":1760123941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/8\/3575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["molecules28083575"],"URL":"https:\/\/doi.org\/10.3390\/molecules28083575","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}